Global "Hormonal
Contraceptive Market" 2025 Industry
research report covers the industry overview with Marketplace Size, Share,
Development, futuristic cost, earnings, demand and distribution data. Its vast
repository offers an analytical summary of the marketplace that can help to the
new and existing player to take a significant decision.
In this report, we
thoroughly examine and analyse the Global market for Hormonal Contraceptive so
that market participants can improve their business strategy and ensure
long-term success. This report provides players with useful information and
suggests result-based ideas to give them a competitive advantage in the global Hormonal
Contraceptive industry. It will show how other players compete in the global Hormonal
Contraceptive Market and explain the strategies you use to differentiate
yourself from other participants.
Download Free Sample
Report Now @ https://www.millioninsights.com/industry-reports/hormonal-contraceptive-market/request-sample
Global Hormonal
Contraceptive Market is expected to reach USD 26.2 billion by 2025. The
hormonal contraceptive is termed as a birth control method, which acts on an
endocrine system. The method is mainly used to prevent ovulation using female
hormones. Progesterone and/or estrogen, or combination of these hormones are
the two main forms of hormonal contraception. These hormones may be implanted
into body tissue, absorbed from a patch on the skin, may be taken orally,
injected under the skin, or placed in the vagina. The Hormonal Contraceptive
Market is estimated to grow at a significant CAGR of 4.0% over the future
period as the scope and its applications are rising enormously across the
globe.
High demand for hormonal
contraception for birth control, growing female population, urbanization and
raised awareness regarding hormonal contraception, and availability of low cost
contraceptive practices are documented as major factors of Hormonal
Contraceptive Market that are estimated to enhance the growth in the years to
come. However, adverse side effects and key barrier for global market are the
factors that may restrain overall market growth in the coming years. Hormonal
Contraceptive Market is segmented based on product type, methods, end use, and
region.
Implantation, oral pill,
injection, skin patch, intrauterine device (IUD), and other products could be
explored in Hormonal Contraceptive Market in the forecast period. Oral pill is
also termed as “the pill” that contains grouping of female hormones, progesterone
and estrogen. The pill helps to prevent the risk of pregnancy by keeping the
lining of the uterus thin and by avoiding ovulation. Intrauterine device (IUD)
is a T-shapes small device, which is implanted into uterus that help to prevent
pregnancy. The effect of device is for many years and can be removed at certain
period. Hormonal IUD and Copper IUD are the two main intrauterine devices.
Sterilization, barrier
method, emergency contraception, and hormonal methods are the methods that
could be explored in Hormonal Contraceptive in the future period. Barrier
method helps to prevent sperm from entering the uterus. Cervical caps,
diaphragms, male condom, female condom, and others are the barrier methods.
Hormonal method use hormones that may be introduced through injections, pills,
vaginal rings, skin patches, and others to stop or regulate ovulation and
prevent pregnancy.
Emergency contraception are
the hormonal pills that are taken with 12 hours as a single dose or a double
dose in case of unprotected intercourse. It helps to inhibit or delay ovulation
for at least 5 days until the sperm become inactive. However, sterilization is
a permanent form of birth control that either prevents a man from releasing
sperm or averts a woman from getting pregnant.
The market may be
categorized based on end users like ambulatory surgical centers, hospitals,
clinics, homecare settings, gynecology centers, and others. Gynecology centers
and hospitals sectors accounted for the majority market share and is estimated
to lead the overall market in the upcoming years. However, other segments are
estimated to grow at fastest pace in the future period.
Globally, North America
accounted for the largest market share of Hormonal Contraceptive in terms of
revenue and is estimated to continue its dominance in the coming years. The
reason behind growth of overall market could be presence of key manufacturers
in the region and comfort of use. Instead, Europe and the Asia Pacific are also
estimated to have a positive influence on the future growth. Europe is the
second largest region with significant market share. However, Asia Pacific is
estimated to grow at fastest pace with the highest CAGR in the foremost period.
The developing countries like India and China are the major consumers of this
market in the region.
The key players of Hormonal
Contraceptive Industry are Teva Pharmaceutical Industries Limited, Bayer Pharma
AG, Agile Therapeutics Inc., Merck & Co., Inc., Charleston, SC., and
Afaxys, Inc. These players are concentrating on inorganic growth to sustain
themselves amongst fierce competition. As such, mergers, acquisitions, and
joint ventures are the need of the hour.
Know
More Insights @ https://newsonmarketblog.wordpress.com
No comments:
Post a Comment